CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin.
Jingbo MaXiaolong XuChunjin FuPeng XiaMing TianLiuhai ZhengKun ChenXiaolian LiuYilei LiLe YuQinchang ZhuYangyang YuRongrong FanHaibo JiangZhifen LiChuanbin YangChengchao XuYing LongJigang WangZhijie LiPublished in: Biomaterials research (2022)
The study presents a novel imaging and drug delivery strategy by targeting CDH17. CDH17 nanobody-based immunotoxin is potentially a promising therapeutic modality for clinical translation against gastric cancer.